HER2 Testing in Metastatic Breast Cancer

In this discussion, panelists discuss the intricacies of HER2 testing in patients with metastatic breast cancer and the potential impact of low expression on the efficacy of HER2-targeted therapies. For more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community